Cannabinoids in Late Life Parkinson’s Disease and Dementia: Biological Pathways and Clinical Challenges

The use of cannabinoids as therapeutic drugs has increased among aging populations recently. Age-related changes in the endogenous cannabinoid system could influence the effects of therapies that target the cannabinoid system. At the preclinical level, cannabidiol (CBD) induces anti-amyloidogenic, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Alana C., Joaquim, Helena P. G., Pedrazzi, João F. C., Pain, Andreia de O., Duque, Gustavo, Aprahamian, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775654/
https://www.ncbi.nlm.nih.gov/pubmed/36552056
http://dx.doi.org/10.3390/brainsci12121596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775654/
https://www.ncbi.nlm.nih.gov/pubmed/36552056
http://dx.doi.org/10.3390/brainsci12121596

Ejemplares similares